GSK buys Tesaro for $5.1bn to boost cancer drugs

Shares lose 7 per cent on news of drugmaker’s first big acquisition under Emma Walmsley
Source: FT.com - Drugs and Healthcare - Category: Pharmaceuticals Source Type: news